Novo Nordisk has lowered its expectations for how much it will grow in 2025. The Danish pharmaceutical company announced this in a statement on Tuesday, 29 July. For the first half of 2025, the ...

Novo Nordisk has named Maziar Mike Doustdar as its new president and chief executive officer. He will take over the role on 7 August 2025, replacing Lars Fruergaard Jørgensen, who will step down the ...